1326PEvaluation of the efficacy and safety of everolimus as a first-line treatment in newly diagnosed patients with advanced gastroenteropancreatic neuroendocrine tumors. (23rd October 2018) - Koumarianou, A; Pectasides, D G; Manousou, K; Dionysopoulos, D; Kaltsas, G A; Kolomodi, D; Poulios, C; Skondra, M; Samantas, E; Pentheroudakis, G; Fountzilas, G